The known MEFV independent genetic modifiers are polymorphisms of IL-1β which is associated with disease severity [66] and harboring alpha/alpha genotype for serum amyloid A protein 1 (SAA1) gene which increases the risk of developing AA amyloidosis without affecting FMF disease characteristics [67]. The gene discussed is SAA1; the disease is AA amyloidosis.